Drug Type Small molecule drug |
Synonyms ZG 2305, ZG2305 |
Target |
Action inhibitors |
Mechanism HIF inhibitors(Hypoxia inducible factors inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H11Cl2N3O5 |
InChIKeyIVVBSKSURSLYFK-UHFFFAOYSA-N |
CAS Registry2962103-54-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fatty Liver | Preclinical | China | 21 Oct 2024 | |
Fatty Liver | Preclinical | United Kingdom | 21 Oct 2024 | |
Obesity | Preclinical | China | 21 Oct 2024 | |
Obesity | Preclinical | United Kingdom | 21 Oct 2024 |